Log In
BCIQ
Print this Print this
 

AT-101

  Manage Alerts
Collapse Summary General Information
Company Ascentage Pharma Group Corp. Ltd.
DescriptionSmall molecule pan inhibitor of Bcl-2 family of proteins
Molecular Target B cell lymphoma 2 (BCL-2) (BCL2) ; Myeloid leukemia cell differentiation protein (MCL1)
Mechanism of ActionBcl-2 inhibitor; Myeloid leukemia cell differentiation protein (Mcl-1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/06/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today